These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 37227882)
1. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882 [TBL] [Abstract][Full Text] [Related]
2. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance. Votaw VR; Pearson MR; Stein E; Witkiewitz K Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027 [TBL] [Abstract][Full Text] [Related]
3. Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder. Stein ER; Votaw VR; Swan JE; Witkiewitz K J Subst Abuse Treat; 2021 Mar; 122():108227. PubMed ID: 33509416 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Nieto SJ; Grodin EN; Green R; Ray LA Drug Alcohol Depend; 2021 Apr; 221():108603. PubMed ID: 33618192 [TBL] [Abstract][Full Text] [Related]
5. Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder. Nieto SJ; Grodin EN; Ray LA Behav Brain Res; 2024 Apr; 464():114926. PubMed ID: 38431152 [TBL] [Abstract][Full Text] [Related]
6. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment. Witkiewitz K; Stein ER; Votaw VR; Hallgren KA; Gibson BC; Boness CL; Pearson MR; Maisto SA Psychol Addict Behav; 2023 May; 37(3):376-389. PubMed ID: 35951419 [TBL] [Abstract][Full Text] [Related]
7. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Nieto SJ; Ray LA Behav Brain Res; 2022 Jun; 427():113876. PubMed ID: 35378110 [TBL] [Abstract][Full Text] [Related]
8. Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery. Gunawan T; Luk JW; Schwandt ML; Kwako LE; Vinson T; Horneffer Y; George DT; Koob GF; Ramchandani VA; Diazgranados N; Goldman D Transl Psychiatry; 2024 Jul; 14(1):271. PubMed ID: 38956031 [TBL] [Abstract][Full Text] [Related]
9. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder. Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440 [TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder. Votaw VR; Stein ER; Witkiewitz K Alcohol Alcohol; 2021 Aug; 56(5):573-580. PubMed ID: 33778864 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal measurement invariance of constructs derived from the addiction cycle. Boness CL; Votaw VR; Stein ER; Hallgren KA; Witkiewitz K Psychol Addict Behav; 2024 Sep; 38(6):649-655. PubMed ID: 38059947 [TBL] [Abstract][Full Text] [Related]
12. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Koob GF; Colrain IM Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199 [TBL] [Abstract][Full Text] [Related]
13. Sex Differences in the Neurobiology of Alcohol Use Disorder. Flores-Bonilla A; Richardson HN Alcohol Res; 2020; 40(2):04. PubMed ID: 33042719 [TBL] [Abstract][Full Text] [Related]
14. Addictions NeuroImaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder. Voon V; Grodin E; Mandali A; Morris L; Doñamayor N; Weidacker K; Kwako L; Goldman D; Koob GF; Momenan R Neurosci Biobehav Rev; 2020 Jun; 113():492-506. PubMed ID: 32298710 [TBL] [Abstract][Full Text] [Related]
15. Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder. Kirsch DE; Grodin EN; Nieto SJ; Kady A; Ray LA Neuropsychopharmacology; 2024 Oct; 49(11):1719-1728. PubMed ID: 38740901 [TBL] [Abstract][Full Text] [Related]
17. Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study. Glöckner-Rist A; Lémenager T; Mann K; Addict Behav; 2013 Feb; 38(2):1532-1540. PubMed ID: 23148916 [TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of the Brief DSM-5 Alcohol Use Disorder Diagnostic Assessment: A systematic replication in a crowdsourced sample. Campbell EM; Strickland JC Addict Behav; 2019 May; 92():194-198. PubMed ID: 30658255 [TBL] [Abstract][Full Text] [Related]
19. A principal components analysis of the abbreviated Desires for Alcohol Questionnaire (DAQ). Kramer JR; Chan G; Hesselbrock VM; Kuperman S; Bucholz KK; Edenberg HJ; Schuckit MA; Nurnberger JI; Foroud T; Dick DM; Bierut LJ; Porjesz B J Stud Alcohol Drugs; 2010 Jan; 71(1):150-5. PubMed ID: 20105425 [TBL] [Abstract][Full Text] [Related]